Frontlight ResearchEarly access
Trial site
Istituto Di Ricerche Farmacologiche Mario Negri
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy4 trials
- Chronic kidney disease3 trials
- Nephrotic syndrome2 trials
- Phase
- Phase 25 trials
- Phase 35 trials
- Status
- Completed6 trials
- Recruiting4 trials
- Lead sponsor
- Mario Negri Institute for Pharmacological Research3 trials
- Novartis Pharmaceuticals2 trials
- AstraZeneca1 trial
- Bayer1 trial
- Biogen1 trial
- and 2 more
Running trials
Recruiting
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Not yet recruiting
Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- IgA nephropathy2 recruiting
- Chronic kidney disease1 recruiting
- Nephrotic syndrome1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026